The latest thought leadership from our expert teams

Active filters (1)
Biotech
Opinion

From glowing flowers to decomposing buildings – it was an illuminating week for biotech in the Bay Area

17th May 2022

From almost three years of pandemic restrictions to a three-day biology bonanza. Senior Biomedical Engineer Ellen Simmons gets back on the live conference trail with a visit to Built With Biology, formerly SynBioBeta. Here she shares her experiences – and enthusiasm for helping to drive the biotech ecosystem forwards… 

  • Bioinnovation
  • Sustainability
  • Synthetic biology
The Engine venture ecosystem
Opinion

CC and The Engine venture ecosystem: an alignment of ambition

28th Apr 2022

We're ramping up our commitment to The Engine, the ambitious venture capital firm spun out of MIT to support ‘Tough Tech’ companies and solve key challenges in climate change, human health and advanced systems.

  • AI & Data Analytics consultancy
  • Bioinnovation
  • Connectivity & IoT
  • Robotics
  • Sensing
Opharmic Vlog
Vlog

Medtech mentoring: reflecting on prize-winning innovation with the CEO of Opharmic Technology

25th Jan 2022

Three months on from the climax of Medtech Innovator Asia Pacific, I sat down with the Cambridge Consultants team to catch up with Langston Suen, Founder and CEO of Opharmic Technology, the Hong Kong start-up that made such a brilliant impression on everyone involved with the programme...

  • Digital health
  • Human factors
  • Physical sciences
Beyond BioData 2021
Opinion

Beyond BioData 2021 – a data sharing vision to improve diagnosis, treatment and wellbeing

26th Nov 2021

Fresh from an in-person visit to BioData World Conference 2021, Andrew Goulter discusses the role big pharma is playing in unlocking a complex new healthcare ecosystem. His hope? That effective data sharing and democratised access will deliver advantages for healthcare professionals and patients alike… 
 

  • Bioinnovation
  • Digital health
  • Human factors
細胞治療にかかる費用や時間の負担は減らせるのか?
Opinion

Can cell therapy become cheaper and easier?

9th Nov 2021

Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in bioinnovation, I’ve been part of a team addressing this issue in an ambitious project with exciting potential…

  • Bioinnovation
  • Human factors
PureSentry:リアルタイムコンタミネーション検出が細胞治療にもたらす変革
Whitepaper

PureSentry: Can real-time contamination detection transform cell therapy manufacture?

9th Nov 2021

PureSentry: Can real-time contamination detection transform cell therapy manufacture? 

  • Bioinnovation
  • Human factors
  • Physical sciences
Webinar

Miniature active implants – the key area for innovation in next-generation drug delivery

29th Oct 2021

Cambridge Consultants Harshal Shah, head of oncology innovations for global medical technology presents on how miniature active implants are key area for innovation in next-generation drug delivery.

  • Digital health
  • Human factors
Webinar

Medtech Connect: Beyond COVID - investigating and innovating for the next generation

29th Oct 2021

Medtech Connect | Beyond COVID-19 - investigating and innovating for the next generation 

  • Digital health
  • Strategic advice
Opinion

Neuropathy screening from diabetic retinopathy images – a deep learning breakthrough

26th Oct 2021

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

  • AI & Data Analytics consultancy
  • Digital health
Webinar

IPAC-RS Webinar: What is a digital biomarker and why is it important?

1st Oct 2021

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. Presented by subject matter experts in the pharmaceutical sciences, this is a unique opportunity to learn about the latest research and regulatory trends focused on digital devices.

  • Digital health
  • Human factors
Opinion

Pathology: time to join the digital world?

22nd Sep 2021

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

  • Digital health
  • Human factors
Webinar

Europe as an innovation powerhouse in ophthalmology

5th Aug 2021

Luis Diaz-Santana, Head of Ophthalmology at Cambridge Consultants, presented at OIS European Showcase virtual conference. Watch his presentation to hear his thoughts on if Europe really is an innovation powerhouse in ophthalmology.

  • Bioinnovation
  • Human factors
  • Physical sciences